Literature DB >> 26584347

Super natural killer cells that target metastases in the tumor draining lymph nodes.

Siddarth Chandrasekaran1, Maxine F Chan1, Jiahe Li1, Michael R King2.   

Abstract

Tumor draining lymph nodes are the first site of metastasis in most types of cancer. The extent of metastasis in the lymph nodes is often used in staging cancer progression. We previously showed that nanoscale TRAIL liposomes conjugated to human natural killer cells enhance their endogenous therapeutic potential in killing cancer cells cultured in engineered lymph node microenvironments. In this work, it is shown that liposomes decorated with apoptosis-inducing ligand TRAIL and an antibody against a mouse natural killer cell marker are carried to the tumor draining inguinal lymph nodes and prevent the lymphatic spread of a subcutaneous tumor in mice. It is shown that targeting natural killer cells with TRAIL liposomes enhances their retention time within the tumor draining lymph nodes to induce apoptosis in cancer cells. It is concluded that this approach can be used to kill cancer cells within the tumor draining lymph nodes to prevent the lymphatic spread of cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Liposomes; Nanotechnology; Natural killer cells; TRAIL; Tumor-draining lymph nodes

Mesh:

Substances:

Year:  2015        PMID: 26584347      PMCID: PMC4684422          DOI: 10.1016/j.biomaterials.2015.11.001

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  51 in total

1.  Dynamic behavior of NK cells during activation in lymph nodes.

Authors:  Hélène Beuneu; Jacques Deguine; Béatrice Breart; Ofer Mandelboim; James P Di Santo; Philippe Bousso
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

Review 2.  Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors:  Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

Review 3.  Tumor metastasis and the lymphatic vasculature.

Authors:  Jonathan P Sleeman; Wilko Thiele
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

4.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

5.  High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP.

Authors:  X Wang; Z An; J Geller; R M Hoffman
Journal:  Prostate       Date:  1999-05-15       Impact factor: 4.104

6.  Cytokine requirements for the growth and development of mouse NK cells in vitro.

Authors:  Jennifer A Toomey; Frances Gays; Don Foster; Colin G Brooks
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

7.  TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

Authors:  Anne Grosse-Wilde; Oksana Voloshanenko; S Lawrence Bailey; Gary M Longton; Uta Schaefer; Andreea I Csernok; Günther Schütz; Erich F Greiner; Christopher J Kemp; Henning Walczak
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  New insights into the role of NK cells in cancer immunotherapy.

Authors:  Maria Salagianni; Constantin N Baxevanis; Michael Papamichail; Sonia A Perez
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

Review 9.  Natural killer cells in human cancer: from biological functions to clinical applications.

Authors:  Estrella Mariel Levy; María Paula Roberti; José Mordoh
Journal:  J Biomed Biotechnol       Date:  2011-04-26

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  20 in total

1.  A simplified method for the efficient purification and refolding of recombinant human TRAIL.

Authors:  Zhenjiang Zhang; Su Bin Hahn; Thong M Cao; Michael R King
Journal:  Biotechnol Prog       Date:  2020-05-11

Review 2.  Innovations in lymph node targeting nanocarriers.

Authors:  Jihoon Kim; Paul A Archer; Susan N Thomas
Journal:  Semin Immunol       Date:  2021-11-24       Impact factor: 11.130

Review 3.  Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.

Authors:  Prakash Gangadaran; Byeong-Cheol Ahn
Journal:  Front Immunol       Date:  2017-09-12       Impact factor: 7.561

Review 4.  Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.

Authors:  Zhenjiang Zhang; Michael R King
Journal:  Cell Mol Bioeng       Date:  2017-07-20       Impact factor: 2.321

5.  A novel treatment for metastatic lymph nodes using lymphatic delivery and photothermal therapy.

Authors:  Adewale O Oladipo; Oluwatobi S Oluwafemi; Sandile P Songca; Ariunbuyan Sukhbaatar; Shiro Mori; Junnosuke Okajima; Atsuki Komiya; Shigenao Maruyama; Tetsuya Kodama
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

6.  Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene Transfer.

Authors:  Elizabeth C Wayne; Christian Long; Matthew J Haney; Elena V Batrakova; Tina M Leisner; Leslie V Parise; Alexander V Kabanov
Journal:  Adv Sci (Weinh)       Date:  2019-09-04       Impact factor: 16.806

7.  Nanoparticle-Laden Macrophages for Tumor-Tropic Drug Delivery.

Authors:  Weizhong Zhang; Mengzhe Wang; Wei Tang; Ru Wen; Shiyi Zhou; Chaebin Lee; Hui Wang; Wen Jiang; Ian Michael Delahunty; Zipeng Zhen; Hongmin Chen; Matthew Chapman; Zhanhong Wu; Elizabeth W Howerth; Houjian Cai; Zibo Li; Jin Xie
Journal:  Adv Mater       Date:  2018-10-11       Impact factor: 30.849

Review 8.  The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance.

Authors:  Hassan Dianat-Moghadam; Mehdi Azizi; Zahra Eslami-S; Luis Enrique Cortés-Hernández; Maryam Heidarifard; Mohammad Nouri; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

Review 9.  Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance.

Authors:  Elaheh Hashemi; Subramaniam Malarkannan
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

Review 10.  Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.

Authors:  Ang Gao; Xian-Li Hu; Madiha Saeed; Bin-Fan Chen; Ya-Ping Li; Hai-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2019-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.